Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetes

被引:0
|
作者
Blicklé, JF [1 ]
Sapin, R
Andrès, E
机构
[1] Hop Civil, Clin Med B, Serv Med Interne B, F-67091 Strasbourg, France
[2] Fac Med Strasbourg, Lab Univ Biophys, Unite Anal Endocriniennes, F-67085 Strasbourg, France
来源
DIABETES & METABOLISM | 2000年 / 26卷 / 04期
关键词
specific insulin; total proinsulin; intact proinsulin; impaired glucose tolerance; obesity; diabetes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent development of specific radioimmunoassays of insulin (Ins) and proinsulin (PI) led some authors to question the classical data on insulinosecretion in patients with abnormal glucose tolerance. The aim of this work was to determine the participation of intact proinsulin (iPI) and its split fragments to total insulinsecretion in obese subjects and in various stages of glucose intolerance determined by an oral glucose load according to the WHO recommendations. Five groups were constituted: non obese controls (C), obese subjects with normal glucose tolerance (O), non obese subjects with impaired glucose tolerance (I), obese subjects with impaired glucose tolerance (OI) and diabetic patients (O). The basal level of total Proinsulin (tPI) of D and OI was significantly higher than that of C, but the tPI/Ins ratio did not differ between the five groups. After glucose load, this ratio tended to be higher in D, but not significantly. No statistical difference between groups was observed for the iPI/Ins ratio. These results indicate that the determination of tPI is at least as informative or more than that of iPI. Furthermore, the proportionally constant participation of PI to insulin secretion observed in various stages of glucose intolerance suggests that the results obtained in the past with non specific insulin radioimmunoassays remain valid.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 50 条
  • [41] Serum levels of p53 and cytochrome c in subjects with type 2 diabetes and impaired glucose tolerance
    Dincer, Yildiz
    Himmetoglu, Solen
    Yalin, Serap
    Damci, Taner
    Ilkova, Hasan
    Akcay, Tulay
    CLINICAL AND INVESTIGATIVE MEDICINE, 2009, 32 (04): : E266 - E270
  • [42] Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes
    Ou, Horng-Yih
    Yang, Ching
    Wu, Hung-Tsung
    Wu, Jin-Shang
    Lu, Feng-Hwa
    Chang, Chih-Jen
    CLINICAL ENDOCRINOLOGY, 2011, 75 (04) : 450 - 455
  • [43] Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and Type 2 diabetes
    S. Neri
    S. Calvagno
    B. Mauceri
    M. Misseri
    A. Tsami
    C. Vecchio
    G. Mastrosimone
    A. Di Pino
    D. Maiorca
    A. Judica
    G. Romano
    A. Rizzotto
    S. S. Signorelli
    European Journal of Nutrition, 2010, 49 : 409 - 416
  • [44] Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes
    Prabu, Paramasivam
    Rome, Sophie
    Sathishkumar, Chandrakumar
    Aravind, Sankaramoorthy
    Mahalingam, Balakumar
    Shanthirani, Coimbatore Subramanian
    Gastebois, Caroline
    Villard, Audrey
    Mohan, Viswanathan
    Balasubramanyam, Muthuswamy
    PLOS ONE, 2015, 10 (05):
  • [45] Effects of antioxidants on postprandial oxidative stress and endothelial dysfunction in subjects with impaired glucose tolerance and Type 2 diabetes
    Neri, S.
    Calvagno, S.
    Mauceri, B.
    Misseri, M.
    Tsami, A.
    Vecchio, C.
    Mastrosimone, G.
    Di Pino, A.
    Maiorca, D.
    Judica, A.
    Romano, G.
    Rizzotto, A.
    Signorelli, S. S.
    EUROPEAN JOURNAL OF NUTRITION, 2010, 49 (07) : 409 - 416
  • [46] Predictors of progression to Type 2 diabetes or regression to normal glucose tolerance in persons with impaired glucose tolerance
    D'Agostino, RB
    Haffner, S
    Bergman, R
    Wagenknecht, L
    Rewers, M
    DIABETES, 2000, 49 : A386 - A387
  • [47] A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T. C.
    Schwartz, S.
    Rosenberg, M. A.
    Jarlwala, N.
    Becker, R. H. A.
    Johnston, P. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (05) : 282 - 288
  • [48] Evaluatioin of the safety, efficacy and tolerability of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T
    Schwartz, S
    Rosenberg, M
    Johnston, P
    Jariwala, N
    Shukla, U
    Becker, R
    Saoud, J
    DIABETES, 2003, 52 : A451 - A452
  • [49] Adipocytes in subjects with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and type 2 diabetes (T2D) are resistant to antilipolytic effect of insulin
    Abdul-Ghani, Muhammad
    Jenkinson, Christopher
    Richardson, Dawn
    Defronzo, Ralph
    DIABETES, 2006, 55 : A305 - A306
  • [50] Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study
    R. M. van Dam
    J. M. Dekker
    G. Nijpels
    C. D. A. Stehouwer
    L. M. Bouter
    R. J. Heine
    Diabetologia, 2004, 47 : 2152 - 2159